
    
      This study is a multiple dose escalating design to evaluate the safety, PK, and
      pharmacodynamics (PD) of multiple subcutaneous injections of SHR-1314. There are two parts in
      this study. The safety, PK, and PD will be evaluated in Part A, the dose escalation part. The
      efficacy and safety on different doses will be assessed in parallel-groups in Part B.
    
  